Show simple item record

dc.contributor.authorShrestha, A.B.
dc.contributor.authorPokharel, P.
dc.contributor.authorSapkota, U.H.
dc.contributor.authorShrestha, S.
dc.contributor.authorMohamed, S.A.
dc.contributor.authorKhanal, S.
dc.contributor.authorJha, S.K.
dc.contributor.authorMohanty, A.
dc.contributor.authorPadhi, B.K.
dc.contributor.authorAsija, A.
dc.contributor.authorSedhai, Y.R.
dc.contributor.authorRijal, R.
dc.contributor.authorSingh, K.
dc.contributor.authorChattu, V.K.
dc.contributor.authorRodriguez-Morales, A.J.
dc.contributor.authorBarboza, J.J.
dc.contributor.authorSah, R.
dc.date.accessioned2025-10-31T18:47:47Z
dc.date.available2025-10-31T18:47:47Z
dc.date.issued2023
dc.identifier.urihttps://hdl.handle.net/20.500.12805/6341
dc.description.abstractBackground: In South Asia, resistance to commonly used antibiotics for the treatment of Helicobacter pylori infection is increasing. Despite this, accurate estimates of overall antibiotic resistance are missing. Thus, this review aims to analyze the resistance rates of commonly used antibiotics for the treatment of H. pylori in South Asia. Methods: The systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement. We searched five medical databases for relevant studies from inception to September 2022. A random effect model with a 95% confidence interval (CI) was used to calculate the pooled prevalence of antibiotic resistance. Results: This systematic review and meta-analysis included 23 articles, 6357 patients, 3294 Helicobacter pylori isolates, and 2192 samples for antibiotic resistance. The prevalences of antibiotic resistance to common antibiotics were clarithromycin: 27% (95%CI: 0.17–0.38), metronidazole: 69% (95%CI: 0.62–0.76), tetracycline: 16% (95%CI: 0.06–0.25), amoxicillin: 23% (95%CI: 0.15–0.30), ciprofloxacin: 12% (95%CI: 0.04–0.23), levofloxacin: 34% (95%CI: 0.22–0.47), and furazolidone: 14% (95%CI: 0.06–0.22). Subgroup analysis showed antibiotic resistances were more prevalent in Pakistan, India, and Bangladesh. Furthermore, a ten-year trend analysis showed the increasing resistance prevalence for clarithromycin (21% to 30%), ciprofloxacin (3% to 16%), and tetracycline (5% to 20%) from 2003 to 2022. Conclusion: This meta-analysis showed a high prevalence of resistance among the commonly used antibiotics for H. pylori in South Asian countries. Furthermore, antibiotic resistance has been increasing over the time of 20 years. In order to tackle this situation, a robust surveillance system, and strict adherence to antibiotic stewardship are required.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofurn:issn:2414-6366
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectHelicobacter Pylori and Gastric Cancer Dynamicsen_US
dc.subjectHelicobacter Pylori Resistance and Treatment Strategiesen_US
dc.titleDrug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Helicobacter pylori Infection among South Asian Countries: A Systematic Review and Meta-Analysisen_US
dc.typehttps://purl.org/coar/resource_type/c_dcae04bc
dc.identifier.doihttps://doi.org/10.3390/tropicalmed8030172
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.00.00
dc.type.otherReview
dc.identifier.journalTropical Medicine and Infectious Disease
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2